First-principles investigation of LiSnAl and LiSiIn half-Heusler compounds for optoelectronic applications
RSC Advances · 2025 · 15 (46) · 38562-38576
DOI: 10.1039/d5ra04779j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Mohshina Binte Mansur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, Khulna University of Engineering & Technology Khulna-9203 Bangladesh jahirul@mse.kuet.ac.bd wrsajal@…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Our findings confirm that both LiSiIn and LiSnAl possess a cubic C1b crystal structure (F4̄3m space group) and satisfy Born’s stability criteria, confirming their mechanical stability.
Autor:innen und Institutionen
- Department of Materials Science and Engineering, Khulna University of Engineering & Technology Khulna-9203 Bangladesh jahirul@mse.kuet.ac.bd wrsajal@nce.buet.ac.bd.
- Department of Nanomaterials and Ceramic Engineering, Bangladesh University of Engineering and Technology Dhaka-1000 Bangladesh.
ORCID-Profile: Jahirul Islam
Zitieren
APA
Mansur, M. B., Akter, T., Ovi, I. A., Islam, J., & Sajal, W. R. (2025). First-principles investigation of LiSnAl and LiSiIn half-Heusler compounds for optoelectronic applications. RSC Advances, 15(46), 38562-38576. https://doi.org/10.1039/d5ra04779j
Vancouver
Mansur MB, Akter T, Ovi IA, Islam J, Sajal WR. First-principles investigation of LiSnAl and LiSiIn half-Heusler compounds for optoelectronic applications. RSC Advances. 2025;15(46):38562-38576. doi:10.1039/d5ra04779j
BibTeX
@article{Mansur2025,
author = {Mansur, Mohshina Binte and Akter, Tasmi and Ovi, Istiak Ahmed and Islam, Jahirul and Sajal, Wahidur Rahman},
title = {First-principles investigation of LiSnAl and LiSiIn half-Heusler compounds for optoelectronic applications},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {46},
pages = {38562--38576},
doi = {10.1039/d5ra04779j}
}
EUVIMED